BioCentury
BioCentury
YouTubeLinkedInXRSS
ARTICLE | Clinical News

VX-950: Phase II started

WIR Staff
May 29, 2006 7:00 AM UTC

VRTX started the U.S. Phase II PROVE 1 trial in 260 treatment-naïve HCV patients. ...

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Cookie Policy
California Privacy Rights
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
YouTubeLinkedInXRSS
BioCentury
© 2025 BioCentury Inc. All Rights Reserved.
Copyright © 2025 BioCentury Inc. All Rights Reserved.
YouTubeLinkedInXRSS